About US
Contact us
-
Ashland will acquire Pharmachem Laboratories Inc.Ashland Global Holdings Inc. ASH, -1.39% a specialty chemicals company serving a range of consumer and industrial markets, said Mondya that it will acquire Pharmachem Laboratories Inc. for $660 millio2017/4/18
-
Takeda and NuBiyota to develop microbial ecosystem therapeutic products for GI indicationsJapanese company Takeda Pharmaceutical Company is all set to collaborate with NuBiyota to develop microbial ecosystem therapeutic products for gastroenterology (GI) indications. Under the partnership2017/4/18
-
Appili to develop new antibiotic to treat gram-negative infectionsAnti-infective drug development company Appili Therapeutics is set to receive funding to support the development of a new antibiotic to treat gram-negative infections. The additional $400,000 funding2017/4/17
-
Austrian scientists modify and reinforce host defence peptide from breast milk to detect cancer cellsScientists at the University of Graz in Austria have modified and reinforced a host defence peptide from breast milk to enable it to specifically detect cancer cells. As part of the project, which ha2017/4/17
-
Immune-Onc and UT System to develop new biotherapeutics for cancer immunotherapyImmune-Onc Therapeutics has entered an agreement with two member institutions of the University of Texas System (UT System) to acquire the global rights to develop and commercialise new biotherapeutic2017/4/14
-
Synergy Pharmaceuticals launches new Poop Troop emoji keyboard app for CICUS-based Synergy Pharmaceuticals has launched a series of 14 animated emojis known as Poop Troop, designed to allow people to better express the physical and emotional impact of chronic idiopathic con2017/4/14
-
Kickbacks judge to Novartis: Hand over the info on those 79,000 'sham' eventsA U.S. judge has ordered Novartis to do something it’s been trying for a year to avoid: Hand over documents on 79,236 educational events the company says it held with doctors. Federal prosecutors cla2017/4/13
-
Democrats, Sanders back massive pharma overhaul in 'landmark' pricing legislationIn the wake of the Republicans' failure to repeal and replace the Affordable Care Act last week, Democrats are stepping in with some proposals of their own. A lot of proposals, in fact, in a"landmark"2017/4/13
-
Senate probe keeps heat on J&J, Mylan, Depomed and others for their opioid marketingOpioid makers have had no shortage of critics in recent years as the United States suffers the sting of a painful addiction epidemic. Now, a top senate Democrat is throwing the weight of her office be2017/4/12
-
Mylan's $465M settlement shortchanges taxpayers: studyWhen the U.S. government agreed on a $465 million Medicaid misclassification settlement with Mylan, did it agree on an amount that was too low? A new study says that’s likely the case. By calculating2017/4/12